CRISPR/Cas‐mediated genome editing to treat EGFR‐mutant lung cancer: a personalized molecular surgical therapy by Huibin Tang, Joseph B Shrager

Get full text

Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer by Kouta Niizuma, Toshinobu Nishimura, Jonathan Villanueva, Laura Amaya, Jonas L. Fowler, Taichi Isobe, Yusuke Nakauchi, Brandon Saavedra, Haojun Xu, Mahito Nakanishi, Adam C. Wilkinson, Kyle M. Loh, Joseph B. Shrager, Hiromitsu Nakauchi

Get full text

Factors and outcomes associated with successful minimally invasive pneumonectomyCentral MessagePerspective by Winston L. Trope, BE, Ntemena Kapula, MS, Irmina A. Elliott, MD, Brandon A. Guenthart, MD, Natalie S. Lui, MD, Leah M. Backhus, MD, Mark F. Berry, MD, Joseph B. Shrager, MD, Douglas Z. Liou, MD

Get full text